These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36768723)

  • 1. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients.
    Izycka N; Rucinski M; Andrzejewska M; Szubert S; Nowak-Markwitz E; Sterzynska K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
    Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
    J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
    Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J
    J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
    Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
    Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
    Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
    Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic Tissues in Patients With Breast Cancer.
    Yamanaka T; Oshima T; Murayama D; Okamoto S; Matsui AI; Yasukawa M; Matsubara Y; Toda S; Hiroshima Y; Aoyama T; Suganuma N; Rino Y; Saito A; Miyagi Y; Iwasaki H; Yamashita T
    Anticancer Res; 2023 May; 43(5):2145-2154. PubMed ID: 37097684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
    Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
    Steg AD; Bevis KS; Katre AA; Ziebarth A; Dobbin ZC; Alvarez RD; Zhang K; Conner M; Landen CN
    Clin Cancer Res; 2012 Feb; 18(3):869-81. PubMed ID: 22142828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.
    Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J
    BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
    Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
    Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44
    Sihombing UHM; Andrijono A; Purwoto G; Gandamihardja S; Harahap AR; Rustamadji P; Kekalih A; Widyawati R; Fuady DR
    J Egypt Natl Canc Inst; 2022 Oct; 34(1):44. PubMed ID: 36274112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact.
    Tsunedomi R; Yoshimura K; Suzuki N; Hazama S; Nagano H
    Surg Today; 2020 Dec; 50(12):1560-1577. PubMed ID: 32025858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
    Roy M; Connor J; Al-Niaimi A; Rose SL; Mahajan A
    Hum Pathol; 2018 Mar; 73():1-6. PubMed ID: 28851663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.